Fung AS, Graham DM, Chen EX, Stockley TL, et al. A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer. Lung Cancer 2021;157:21-29.
PMID: 34052705